NEW YORK, April 12 - Spotfire is expected to announce on Monday that privately held biotech company Microbia has bought its DecisionSite software to help its anti-infective drug-discovery research.
Microbia will integrate the Spotfire software with its Oracle-based application SCOPE, which stores biological-screening data, and with MDL Information Systems' ISIS Host, which stores the chemical properties of select compounds.
"We're building an advanced drug-discovery platform around our SCOPE system," said Kevin Durfee, Microbia's director of IT. "Spotfire is a critical piece of that system and provides a strategic advantage for our company."
Financial terms of the deal were not disclosed.